Circulating ketone bodies and risk of incident atrial fibrillation: insights from the MESA and UK Biobank cohorts.

IF 7.5 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Vardhmaan Jain, Parag Anilkumar Chevli, Parveen K Garg, James Thomas McParland, Jorge Kizer, Kenneth Mukamal, Christopher L Schaich, Rishi Rikhi, Margery Connelly, Ambarish Pandey, Sadiya Khan, Susan R Heckbert, Michael D Shapiro
{"title":"Circulating ketone bodies and risk of incident atrial fibrillation: insights from the MESA and UK Biobank cohorts.","authors":"Vardhmaan Jain, Parag Anilkumar Chevli, Parveen K Garg, James Thomas McParland, Jorge Kizer, Kenneth Mukamal, Christopher L Schaich, Rishi Rikhi, Margery Connelly, Ambarish Pandey, Sadiya Khan, Susan R Heckbert, Michael D Shapiro","doi":"10.1093/eurjpc/zwaf543","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Circulating ketone bodies (KB) are an important source of metabolic fuel for the myocardium under physiological and pathological conditions. Prior studies have linked KB levels with adverse cardiovascular outcomes. However, their relationship with atrial fibrillation (AF) risk remains unknown. The objective is to evaluate the association of KB levels with the risk of incident AF.</p><p><strong>Methods and results: </strong>This prospective, multicentre cohort study recruited patients without baseline AF from the Multi-Ethnic Study of Atherosclerosis (MESA) and the UK Biobank (UKB), respectively. Total KB levels were measured by nuclear magnetic resonance spectroscopy in both studies. The associations between total and individual KB and incident AF were evaluated using multivariable-adjusted Cox proportional hazard models. Prespecified interaction analyses were performed for smoking status, history of diabetes mellitus, history of hypertension, body mass index, and self-reported race/ethnicity (to represent a social construct). A total of 6783 participants [mean (standard deviation, SD) age 62 (10) years, 52% women, 38% White, 27.5% Black, 21.8% Hispanic, and 11.6% Chinese American] from MESA and 116 480 participants [mean (SD) age 56.5 (8) years, 54% women, 94% White] from the UKB were included. Over a median follow-up of 16.5 (10.3-17.4) years in MESA and 13.6 (12.8-14.4) years in the UKB, higher levels of total KB were associated with a higher risk of incident AF. In MESA, each doubling of baseline total KB levels was associated with a 1.08-fold increased hazard of incident AF on follow-up [95% confidence interval (CI): 1.00-1.16] after adjustment for confounding factors. Consistent results were obtained in a subgroup analysis stratified by different types of KB (β-hydroxybutyrate, acetoacetate, and acetone). There was a significant interaction with current smoking, such that per doubling of total KB levels was associated with a 1.32-fold increased hazard for incident AF in current smokers (95% CI: 1.08-1.61), but this association was not seen among former/never smokers [hazard ratio (95% CI): 1.05 (0.95-1.13)]. These results were replicated in the UKB.</p><p><strong>Conclusion: </strong>Higher concentrations of KB are associated with an increased risk of AF in predominantly healthy, community-based cohorts, acknowledging that many participants also had comorbidities such as hypertension and diabetes, particularly among smokers. Ketone bodies could serve as a potential biomarker for identifying populations at risk for AF.</p>","PeriodicalId":12051,"journal":{"name":"European journal of preventive cardiology","volume":" ","pages":""},"PeriodicalIF":7.5000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of preventive cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurjpc/zwaf543","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Circulating ketone bodies (KB) are an important source of metabolic fuel for the myocardium under physiological and pathological conditions. Prior studies have linked KB levels with adverse cardiovascular outcomes. However, their relationship with atrial fibrillation (AF) risk remains unknown. The objective is to evaluate the association of KB levels with the risk of incident AF.

Methods and results: This prospective, multicentre cohort study recruited patients without baseline AF from the Multi-Ethnic Study of Atherosclerosis (MESA) and the UK Biobank (UKB), respectively. Total KB levels were measured by nuclear magnetic resonance spectroscopy in both studies. The associations between total and individual KB and incident AF were evaluated using multivariable-adjusted Cox proportional hazard models. Prespecified interaction analyses were performed for smoking status, history of diabetes mellitus, history of hypertension, body mass index, and self-reported race/ethnicity (to represent a social construct). A total of 6783 participants [mean (standard deviation, SD) age 62 (10) years, 52% women, 38% White, 27.5% Black, 21.8% Hispanic, and 11.6% Chinese American] from MESA and 116 480 participants [mean (SD) age 56.5 (8) years, 54% women, 94% White] from the UKB were included. Over a median follow-up of 16.5 (10.3-17.4) years in MESA and 13.6 (12.8-14.4) years in the UKB, higher levels of total KB were associated with a higher risk of incident AF. In MESA, each doubling of baseline total KB levels was associated with a 1.08-fold increased hazard of incident AF on follow-up [95% confidence interval (CI): 1.00-1.16] after adjustment for confounding factors. Consistent results were obtained in a subgroup analysis stratified by different types of KB (β-hydroxybutyrate, acetoacetate, and acetone). There was a significant interaction with current smoking, such that per doubling of total KB levels was associated with a 1.32-fold increased hazard for incident AF in current smokers (95% CI: 1.08-1.61), but this association was not seen among former/never smokers [hazard ratio (95% CI): 1.05 (0.95-1.13)]. These results were replicated in the UKB.

Conclusion: Higher concentrations of KB are associated with an increased risk of AF in predominantly healthy, community-based cohorts, acknowledging that many participants also had comorbidities such as hypertension and diabetes, particularly among smokers. Ketone bodies could serve as a potential biomarker for identifying populations at risk for AF.

循环酮体和房颤事件的风险:来自MESA和UK Biobank队列的见解。
目的:循环酮体(KB)是生理和病理条件下心肌代谢燃料的重要来源。先前的研究已将KB水平与不良心血管结局联系起来。然而,它们与房颤(AF)风险的关系尚不清楚。目的是评估KB水平与AF发生风险的关系。方法和结果:这项前瞻性、多中心队列研究分别从多种族动脉粥样硬化研究(MESA)和英国生物银行(UKB)中招募无基线AF的患者。两项研究均采用核磁共振波谱法测定总KB水平。使用多变量校正Cox比例风险模型评估总KB和个体KB与事件AF之间的关系。对吸烟状况、糖尿病史、高血压史、体重指数和自我报告的种族/民族(代表一种社会结构)进行预先指定的相互作用分析。来自MESA的6783名参与者[平均(标准差,SD)年龄62(10)岁,52%女性,38%白人,27.5%黑人,21.8%西班牙裔和11.6%华裔美国人]和来自UKB的116 480名参与者[平均(标准差,SD)年龄56.5(8)岁,54%女性,94%白人]被纳入。在MESA的中位随访时间为16.5(10.3-17.4)年,UKB的中位随访时间为13.6(12.8-14.4)年,较高的总KB水平与较高的AF发生风险相关。在MESA中,基线总KB水平每增加一倍,随访中AF发生风险增加1.08倍[95%置信区间(CI): 1.00-1.16]。在不同类型KB (β-羟基丁酸酯、乙酰乙酸酯和丙酮)分层的亚组分析中获得了一致的结果。与当前吸烟有显著的相互作用,例如,总KB水平每增加一倍,当前吸烟者发生房颤的风险增加1.32倍(95% CI: 1.08-1.61),但在前吸烟者/从不吸烟者中未见这种关联[风险比(95% CI): 1.05(0.95-1.13)]。这些结果在英国也得到了证实。结论:在以社区为基础的健康人群中,较高的KB浓度与房颤风险增加相关,承认许多参与者也有合并症,如高血压和糖尿病,特别是吸烟者。酮体可以作为识别房颤高危人群的潜在生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European journal of preventive cardiology
European journal of preventive cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
12.50
自引率
12.00%
发文量
601
审稿时长
3-8 weeks
期刊介绍: European Journal of Preventive Cardiology (EJPC) is an official journal of the European Society of Cardiology (ESC) and the European Association of Preventive Cardiology (EAPC). The journal covers a wide range of scientific, clinical, and public health disciplines related to cardiovascular disease prevention, risk factor management, cardiovascular rehabilitation, population science and public health, and exercise physiology. The categories covered by the journal include classical risk factors and treatment, lifestyle risk factors, non-modifiable cardiovascular risk factors, cardiovascular conditions, concomitant pathological conditions, sport cardiology, diagnostic tests, care settings, epidemiology, pharmacology and pharmacotherapy, machine learning, and artificial intelligence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信